Iofina plc

Iofina plc specializes in the exploration and production of iodine, its specialized chemical derivatives, produced water, and natural gas, with operations spanning the United States and the United Kingdom. The company supplies a broad range of products, including halogen chemicals, disinfectants, electronic specialty gases, sanitizers, heat stabilizers, preservatives, and various specialty intermediates. Additionally, it offers solutions for animal health, mineral separation, and odor control. These diverse offerings cater to numerous sectors such as electronics/semiconductor, pharmaceutical, food and beverage, personal care, paints and coatings, dairy, chemical intermediates, gemological, fish and wildlife, and nylon markets. Beyond its own production activities, Iofina also provides comprehensive, fee-based mid-stream services to enable third-party brine stream operators to efficiently extract iodine. Founded in 2005, Iofina plc maintains its headquarters in London, United Kingdom.

Iofina plc trades as IOF.L on LSE. The company is classified in Basic Materials / Chemicals - Specialty and reports in GBP.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £67.91M of revenue and £8.03M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Iofina plc can be compared against peers such as First Tin Plc, 80 Mile Plc, Asiamet Resources Limited, Cobra Resources plc, Haydale Graphene Industries plc, Helix Exploration PLC.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £86.34M, beta of 0.86, and return on equity of +14.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

IOF.L currently shows total debt of £6.66M and beta of 0.86. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.iofina.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.